chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Broken blood vessel in eye; This is a spontaneous report from a contactable consumer (patient).  A patient of unspecified age and gender received the 1st dose of bnt162b2 (BNT162B2) at single dose on 21Dec2020 for Covid-19 immunisation.   The patient medical history and concomitant medications were not reported.  The patient experienced broken blood vessel in eye on 27Dec2020. The outcome of events was unknown. The reporter considered there was not a reasonable possibility that the event broken blood vessel in eye was related to the vaccine.  He was supposed to get second dose, but he did not know whether to get itor not.  Information on the lot/ batch number has been requested.; Sender's Comments: There is not a reasonable possibility that event broken blood vessel in eye is related to BNT162B2.  The event is most likely intercurrent medical condition.
Information has been received via a company representative, from a female nurse (age not specified) with diabetes, who in October 2007, was vaccinated in the arm with a dose of pneumococcal 23v polysaccharide vaccine (lot # not reported), and with a dose influenza virus vaccine (unspecified). In October 2007, following the vaccinations (duration to onset not specified), the nurse developed a temperature of 103 degrees, and "felt like her arm where vaccinations occurred was going to fall off." Subsequently, the nurse recovered (duration of events not specified). The nurse did not seek medical attention. Additional information has been requested.
Chills stated 04/25/2021 around 3:00am got up around 8:30am took Tylenol. Felt really tired all day some muscle ache sore arm. Took hot shower later that day took another Tylenol around 9:00pm and went to bed around 10:00pm. Woke up Monday morning around 6:15am felt much better.
pimply growth on left upper eyelid up in the eyelash line; spots (a little longer) around and below left eye; feel burnish; This spontaneous case was reported by a consumer and describes the occurrence of HORDEOLUM (pimply growth on left upper eyelid up in the eyelash line), EYE PRURITUS (spots (a little longer) around and below left eye) and FEELING HOT (feel burnish) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B31A) for COVID-19 vaccination.     The patient's past medical history included No adverse event since an unknown date.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced HORDEOLUM (pimply growth on left upper eyelid up in the eyelash line), EYE PRURITUS (spots (a little longer) around and below left eye) and FEELING HOT (feel burnish). At the time of the report, HORDEOLUM (pimply growth on left upper eyelid up in the eyelash line), EYE PRURITUS (spots (a little longer) around and below left eye) and FEELING HOT (feel burnish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
On 1-19-17 patient could not lift her arm (area where she got the injection) on 1-20-17. Patient noticed redness on and around injection site - also it became swollen and warm.
Got sick the night got the vaccine. Sore arm, nauseaous, couldn't breathe, didn't want to move; Got sick the night got the vaccine. Sore arm, nauseaous, couldn't breathe, didn't want to move; Got sick the night got the vaccine. Sore arm, nauseaous, couldn't breathe, didn't want to move; Got sick the night got the vaccine. Sore arm, nauseaous, couldn't breathe, didn't want to move; This is a spontaneous report from a contactable consumer.  A 61-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 61-year-old) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date after first dose,, the patient experienced got sick the night got the vaccine. sore arm, nauseaous, couldn't breathe, didn't want to move. The outcome of the events were unknown.   No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Patient mentioned she was afraid of needles and also mentioned she's fainted from getting blood drawn.  Technician told her to relax and then gave her the vaccine.  Pt stated she was feeling dizzy, technician told her to sit and rest.  Pt fell off her chair & blacked out
Patient woke 2 days after vaccine (8-10-11) w/swelling/redness in right deltoid area. Localized swelling only. Examined by physician and diagnosed as local reaction.
pt recv vax &  devel pain @ inj site x 1wk;no other problems;
Pt. came into the clinic (IMMS Dept.) and stated that the next day after she received the vaccine, she noticed redness, swollen and warm to touch on the injection site. Pt. denies any fever or SOB. Advised pt. to apply cold compress on the injection site and take pain medication over the counter. Advised pt. to call the clinic or go to ER if the symptoms get worst. Pt. verbalized understood.
Approx 1 hour after receiving H1N1 shot became "really hot and very dizzy" Couldn't feel feet - they were numb, also developed pruritic rash on upper chest.
Chills and a headache as well as congestion. Took some Theraflu but that didn't seem to help at all.
hx of viral encephalitis p/vax-in coma x 5 days; MD states it was reaction to vax; but no lab work ever came back pos to confirm react to vax;
A non-serious spontaneous report of administration of expired product was received from a clinic administrator concerning a 5-year-old female subsequent to the administration of FLUMIST. The patient's medical history and concomitant medications were not reported. On 22-Feb-2010, the patient was administered FLUMIST. There was no adverse event associated with this vaccination error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. No late occurring adverse events were reported. Additional information was received on 13-May-2010 and incorporated into the narrative: information on late occurring adverse events.
Head ache started 1 hour after vaccine, concerned because mom got same vaccine and also had HA start about same time.
tiredness after the second dose; This spontaneous case was reported by an other health care professional and describes the occurrence of FATIGUE (tiredness after the second dose) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 015M20A) for COVID-19 vaccination.     Concomitant products included PYRIDOXINE HYDROCHLORIDE (VIT B6) and COLECALCIFEROL (D3) for General physical condition normal, VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL) for Herpes NOS, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced FATIGUE (tiredness after the second dose). On 18-Feb-2021, FATIGUE (tiredness after the second dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.     No treatment was reported.         Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Non Significant follow up
Swelling, redness, warmth, and tenderness over left upper outer arm, where vaccines were administered. He received Menactra and Tdap at school. He came to see me in my office on 11/05/2015. He was rx'd TMP/SMX to take BID x 5 days, on 11/8/15 the symptoms were resolved.
Numbness, pain, and weakness in extremidies.  Walking is difficult on some days.  Basic tasks like opening a ziplock bag can be a challenge.  Getting worse over time.  Treated with 300mg daily gabapentin after about 60 days of pain with positive results.
Fever up to 101.5 degrees F; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old, non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration on 07May2021 at 15:00 in the left arm (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08May2021 at 08:00, one day after the second dose of the vaccination, the patient experienced fever up to 101.5 degrees Fahrenheit. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fever up to 101.5 degrees Fahrenheit was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
On 05/05/2000 the patient developed an injection site rash. The patient had no known wild type exposure and was afebrile. The patient sought unspecified medical treatment. At the time of reporting the patient had not recovered. Additional information has been requested.
Nausea; Really bad headaches/headaches continuously all day long; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Really bad headaches/headaches continuously all day long) and NAUSEA (Nausea) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21-2A) for COVID-19 vaccination.     Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA), QUETIAPINE FUMARATE (SEROQUEL), BACLOFEN, PLECANATIDE (TRULANCE), AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, ESOMEPRAZOLE MAGNESIUM (NEXIUM 1-2-3), HYDROCODONE BITARTRATE, PARACETAMOL (LORCET PLUS) and CELECOXIB (CELEBREX) for an unknown indication.   On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced HEADACHE (Really bad headaches/headaches continuously all day long). On an unknown date, the patient experienced NAUSEA (Nausea). At the time of the report, HEADACHE (Really bad headaches/headaches continuously all day long) and NAUSEA (Nausea) outcome was unknown.        Treatment included paracetamol.
Same day he took vax felt legs weakness. Body ached started the 7th. On the 9th he has strep throat.
Pt turned pale and became unresponsive after injection given-vasovagal syncope, pt left clinic 15 minutes later and was feeling fine.
Vaccine admin 4/18/14, small blister back of (R) arm at inj site 4/19/14, 4/20/14 swelling and erythema developed and blister became larger 4/20/14.
Pt recv vax & devel fever, chills, malaise, h/a & fatigue. Pt seen in ER; Tx bed rest, fluids & Tylenol. 15 pts exp this event. Not all identifiable. This is 1of 2 reports from this site w/adverse rxn lot#4978002.
He tested positive for COVID-19 on 1/23/23. He had a low-grade fever, and congestion. He had Rhinovirus the week before he tested positive for COVID-19. So, I think his chest congestion was due to that. He has a nebulizer, and we gave him a breathing treatment in the mornings, and we also gave him Children's Motrin. No other medications were prescribed. He is back to normal now.
Within 15 min of vaccine administration patient was standing to leave felt nauseous, pallor, diaphoretic. Vomited, color greyish, patient felt dizzy as if going to pass out.
Information has been received from a physician, concerning a female patient who never was sexually active presented with positive Pap test with high risk of HPV after receiving all three doses of GARDASIL. The patient sought medical attention, she saw the physician. There was no product quality complaint. Additional information is expected.
Fever on 19SEP2020 lasting one day. Rash similar to active measles, not roseola, starting on 22SEP2020 lasting to 24SEP2020.  No additional treatment needed.
pt recvd vax & did not devel a titer p/8 wks;MD reported approx 14 patients;pts assigned WAES 95081597 & 95081815 through 95081827
The patient developed injection site pain, warmth, "muscle tightness", intermittent numbness that waxes and weans. These symptoms started after the injection was given and persisted. Advised follow up with clinic  or PCP today for further assessment/treatment.
The patient received the shot on 12/31/20 in the morning around 10:20am by that evening the patient had a low grade fever. The next day (1/1/21) the patient had a fever of 103.5F. There were no urgent care appointments available so the patient waited until 1/2/21 to go to the ER. At this point the patient states that the injection site was hot to the touch and the redness was 3 inches in width and 1 inch in height. After examination the doctor suspected an intramuscular injection abscess. The doctor told the patient to monitor and use a warm/moist compress and to return if it got worse. The incident was reported to me on 1/4/21 at which point the patient said that the injection site had healed slightly.  I told the patient that I would call her back in a couple of days to follow up and check on her.
Pt felt woozy after recieving 3rd vaccine(HPV). MD present,SBP70's, Bradycardia HR 50's. Amonia inhalent administered. Pt taken to urgent care via wheelchair
Subsequent to receiving vax, pt developed an injection site reaction characterized by hypopigmentation, adipose changes, induration in which 2 fingers can fit and an area of swelling the size of an orange.
(R) Knee/Leg pain and difficulty going up stairs (intermittant). parents waited 1 wk then went to emergency dept. Then she started to have abnormal gait and seemed off balance. Nerology admitted for GBS, had no DTR in lower Legs. - admitted to hospital given IVIG & started PT. as of 11/30/19 she was walking well.
Arm warm red and swollen. Decreased ROM and fever to 102 started that night and lasted few days.
Became red & swollen @ the site as big as a baseball; no fever, flu sx;
Within 30 minutes of receiving vaccination  started having minor nerve sensations at random places throughout body. The sensations (pins & needles, itching, crawling, tingling and minor energy zaps well below skin)  continued regularly  but were never severe.    On April 10th I started taking. 1 tsp of L-glutamine Supplement which I have previously taken with no issues.  Neurological paresthesia increased once I?ve started taking supplements. After about one week I made the connection and stopped. Symptoms decreased but have not ceased. Rather they went back to levels they were before taking the L glutamine.
pt recved vax 9JUL93; was seen in ER; c/o chest tightness, dyspnea, shakiness; given EPi;
11/11/21 @ 0900 PT found on floor of bathroom. PT experienced nausea, dizziness; BP 77/50 HR 98; PT complained of SOB and chest pain. Emergency number was called, PT transported to ED, PT admitted to hospital; diagnosis of idiopathic pericarditis.  PT discharged with medication Colchicine 0.6mg PO BID X14 days. PT readmitted to our facility 11/12 @1950. PT will need follow-up with medical consultant following post hospitalization.
Rash on forehead and on (R) temple area. Observed child for total 30minutes, no further spread or any other symptoms. No itching noted.
Symptoms started last night left arm very painful unable to move arm and could not sleep from pain. This morning left arm with had bump and red round swelling from site.
13OCT93 recvd flu inject & 14OCT(3 6PM itching/redness on lt arm; 15OCT93 wheal noticed 2" from inject & swelling of lt arm; t101 430AM nausea & dry cough;
Patient very sick after receiving the Moderna COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Patient very sick after receiving the Moderna COVID-19 vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Patient very sick after receiving the Moderna COVID-19 vaccine). At the time of the report, VACCINATION COMPLICATION (Patient very sick after receiving the Moderna COVID-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
suspected vaccination failure/had vaccine, still had a light case eyebrow; had light case on eyebrow, went into eye; painful; had light case on eyebrow, went into eye; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), ophthalmic herpes zoster (serious criteria GSK medically significant), pain and shingles. On an unknown date, the outcome of the vaccination failure and pain were unknown and the outcome of the ophthalmic herpes zoster and shingles were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster, pain and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 9-Oct-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient had the vaccine but still had a light case on his/her eyebrow that went into his/her eye.  The patient stated that it as painful but not as bad as it could have been. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Patient states rash began to appear on Monday following the vaccine.  It started on neck, went down arms, back, and some on chest.    After steroid shot, patient has since been experiences hives along with intense burning and itching.
left arm feels like it is tickling; ike she hit her funny bone; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 16Oct2023 as dose 1, single (Lot number: Unknown) at the age of 60 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "cancer" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Comirnaty (Primary series), for covid-19 immunisation. The following information was reported: SKELETAL INJURY (non-serious) with onset Oct2023, outcome "not recovered", described as "ike she hit her funny bone"; PARAESTHESIA (non-serious) with onset Oct2023, outcome "not recovered", described as "left arm feels like it is tickling". Additional information: the patient is having an adverse reaction or thinks she is having a reaction and can't seem to find out about it or wonders if anyone has reported this but the vaccine was administered to her left arm and since she received it in her left arm, she is not having a fever or a break out but it feels like it is tickling and like she hit her funny bone and it is all the time.  It does not last all day but it is every now and then and she has to shake her arm and feels like tickling and she did not have this before the vaccine. This dose of the covid vaccine was administered 16Oct2023 and the arm feeling like it was tickling began about a week after she got the vaccination and she started to notice it and thought what's wrong with her arm and the tickling is ongoing and persisting.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
5x5 inches area hot to the touch; 5-inch by 5-inch reddened, raised; Soreness to arm where had the injection; This spontaneous case was reported by a health care professional and describes the occurrence of INJECTION SITE WARMTH (5x5 inches area hot to the touch), INJECTION SITE ERYTHEMA (5-inch by 5-inch reddened, raised) and INJECTION SITE PAIN (Soreness to arm where had the injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced INJECTION SITE WARMTH (5x5 inches area hot to the touch), INJECTION SITE ERYTHEMA (5-inch by 5-inch reddened, raised) and INJECTION SITE PAIN (Soreness to arm where had the injection). On 17-Apr-2021, INJECTION SITE WARMTH (5x5 inches area hot to the touch), INJECTION SITE ERYTHEMA (5-inch by 5-inch reddened, raised) and INJECTION SITE PAIN (Soreness to arm where had the injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment medication was not provided.   Reporter did not allow further contact
103.3 Fever started 19 hours after injection lasting until Tuesday AM around 6.  Chest wheezing and burning started on day 2 post vaccination lasting for 3 additional days past fever ending. Extreme tiredness and body aches until the fever went away on Tuesday am.
Immediately after receiving the injection she became dizzy and lightheaded.  She decided to drive home and on her way her face began to tingle and her nose became stuffy.  She drove the rest of the way home and after 30-60 minutes her throat became thick and it started to become difficult to breathe.  She called 911 and administered an epi pen that she had at home due to anaphylaxis in 2015.  She was treated by the paramedics and declined going to the ER.  She has more tingling in her face when she was getting ready for bed but this subsided on it's own.